Gonadotropin Releasing Hormone Receptor Agonist

Name
Gonadotropin Releasing Hormone Receptor Agonist
Accession Number
DBCAT003246
Description
Not Available
Drugs
DrugDrug Description
LeuprolideA protein-based luteinizing hormone agonist used to treat prostate cancer, endometriosis, and precocious puberty.
GoserelinA synthetic analog of luteinizing hormone-releasing hormone used to treat breast cancer and prostate cancer by reducing secretion of gonadotropins from the pituitary.
NafarelinA gonadotropin releasing hormone agonist used to treat central precocious puberty.
HistrelinA GnRH agonist found in subcutaneous implants used for the treatment of pediatric patients with central precocious puberty and the palliative treatment of advanced prostate cancer.
TriptorelinA GnRH agonist indicated for the palliative treatment of advanced prostate cancer.
Drugs & Drug Targets
DrugTargetType
LeuprolideGonadotropin-releasing hormone receptortarget
LeuprolideCytochrome P450 3A4enzyme
GoserelinLutropin-choriogonadotropic hormone receptortarget
GoserelinGonadotropin-releasing hormone receptortarget
NafarelinGonadotropin-releasing hormone receptortarget
NafarelinPutative gonadotropin-releasing hormone II receptortarget
HistrelinGonadotropin-releasing hormone receptortarget
TriptorelinGonadotropin-releasing hormone receptortarget